Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 Jul;83(13):4904–4907. doi: 10.1073/pnas.83.13.4904

Characterization of somatomedins from human fetal brain: identification of a variant form of insulin-like growth factor I.

V R Sara, C Carlsson-Skwirut, C Andersson, E Hall, B Sjögren, A Holmgren, H Jörnvall
PMCID: PMC323852  PMID: 3460078

Abstract

A fetal form of somatomedin (insulin-like growth factor) that crossreacts in the fetal brain radioreceptor assay has been proposed to exist in humans. Using this assay to monitor activity during purification, we have isolated a variant form of insulin-like growth factor I (IGF-I) from human fetal brain tissue. The variant IGF-I showed potent crossreaction in the fetal brain radioreceptor assay and stimulated DNA synthesis in fetal brain cells in vitro. Structural analysis revealed the variant IGF-I to have a truncated NH2-terminal region compared to IGF-I isolated from serum. An additional peptide, which displayed less potent crossreaction in the fetal brain radioreceptor assay, was also isolated from the human fetal brain. Partial amino acid sequence analysis revealed identity to insulin-like growth factor II.

Full text

PDF
4904

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Enberg G., Carlquist M., Jörnvall H., Hall K. The characterization of somatomedin A, isolated by microcomputer-controlled chromatography, reveals an apparent identity to insulin-like growth factor 1. Eur J Biochem. 1984 Aug 15;143(1):117–124. doi: 10.1111/j.1432-1033.1984.tb08349.x. [DOI] [PubMed] [Google Scholar]
  2. Enberg G., Tham A., Sara V. R. The influence of purified somatomedins and insulin on foetal rat brain DNA synthesis in vitro. Acta Physiol Scand. 1985 Oct;125(2):305–308. doi: 10.1111/j.1748-1716.1985.tb07720.x. [DOI] [PubMed] [Google Scholar]
  3. Hall K., Brandt J., Enberg G., Fryklund L. Immunoreactive somatomedin A in human serum. J Clin Endocrinol Metab. 1979 Feb;48(2):271–278. doi: 10.1210/jcem-48-2-271. [DOI] [PubMed] [Google Scholar]
  4. Hall K., Sara V. R. Growth and somatomedins. Vitam Horm. 1983;40:175–233. doi: 10.1016/s0083-6729(08)60435-5. [DOI] [PubMed] [Google Scholar]
  5. Haselbacher G. K., Schwab M. E., Pasi A., Humbel R. E. Insulin-like growth factor II (IGF II) in human brain: regional distribution of IGF II and of higher molecular mass forms. Proc Natl Acad Sci U S A. 1985 Apr;82(7):2153–2157. doi: 10.1073/pnas.82.7.2153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jansen M., van Schaik F. M., Ricker A. T., Bullock B., Woods D. E., Gabbay K. H., Nussbaum A. L., Sussenbach J. S., Van den Brande J. L. Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature. 1983 Dec 8;306(5943):609–611. doi: 10.1038/306609a0. [DOI] [PubMed] [Google Scholar]
  7. Jansen M., van Schaik F. M., van Tol H., Van den Brande J. L., Sussenbach J. S. Nucleotide sequences of cDNAs encoding precursors of human insulin-like growth factor II (IGF-II) and an IGF-II variant. FEBS Lett. 1985 Jan 7;179(2):243–246. doi: 10.1016/0014-5793(85)80527-5. [DOI] [PubMed] [Google Scholar]
  8. Kalb V. F., Jr, Bernlohr R. W. A new spectrophotometric assay for protein in cell extracts. Anal Biochem. 1977 Oct;82(2):362–371. doi: 10.1016/0003-2697(77)90173-7. [DOI] [PubMed] [Google Scholar]
  9. Reeve A. E., Eccles M. R., Wilkins R. J., Bell G. I., Millow L. J. Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature. 1985 Sep 19;317(6034):258–260. doi: 10.1038/317258a0. [DOI] [PubMed] [Google Scholar]
  10. Rinderknecht E., Humbel R. E. Primary structure of human insulin-like growth factor II. FEBS Lett. 1978 May 15;89(2):283–286. doi: 10.1016/0014-5793(78)80237-3. [DOI] [PubMed] [Google Scholar]
  11. Rinderknecht E., Humbel R. E. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem. 1978 Apr 25;253(8):2769–2776. [PubMed] [Google Scholar]
  12. Sara V. R., Hall K., Misaki M., Fryklund L., Christensen N., Wetterberg L. Ontogenesis of somatomedin and insulin receptors in the human fetus. J Clin Invest. 1983 May;71(5):1084–1094. doi: 10.1172/JCI110858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sara V. R., Hall K., Rodeck C. H., Wetterberg L. Human embryonic somatomedin. Proc Natl Acad Sci U S A. 1981 May;78(5):3175–3179. doi: 10.1073/pnas.78.5.3175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sara V. R., Hall K. Somatomedins and the fetus. Clin Obstet Gynecol. 1980 Sep;23(3):765–778. [PubMed] [Google Scholar]
  15. Svoboda M. E., Van Wyk J. J., Klapper D. G., Fellows R. E., Grissom F. E., Schlueter R. J. Purification of somatomedin-C from human plasma: chemical and biological properties, partial sequence analysis, and relationship to other somatomedins. Biochemistry. 1980 Feb 19;19(4):790–797. doi: 10.1021/bi00545a027. [DOI] [PubMed] [Google Scholar]
  16. Zumstein P. P., Lüthi C., Humbel R. E. Amino acid sequence of a variant pro-form of insulin-like growth factor II. Proc Natl Acad Sci U S A. 1985 May;82(10):3169–3172. doi: 10.1073/pnas.82.10.3169. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES